The effectiveness of fecal microbiota transplantation (FMT) in treating ulcerative colitis depends on a small set of beneficial bacterial strains, suggests a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Back to News
Weill Cornell MedicineOffice of External Affairs
1300 York AvenueBox 314
New York, NY 10065
Phone: (646) 962-9476